Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Target Price at $4.00

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have earned an average recommendation of “Hold” from the four ratings firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $4.00.

A number of research firms have commented on BIOX. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, December 29th. Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a report on Friday, January 2nd.

Bioceres Crop Solutions Stock Performance

Shares of BIOX opened at $0.39 on Friday. The company’s 50 day simple moving average is $0.65 and its 200-day simple moving average is $1.26. The firm has a market cap of $24.72 million, a PE ratio of -0.11 and a beta of 0.53. Bioceres Crop Solutions has a 12-month low of $0.35 and a 12-month high of $5.18. The company has a current ratio of 0.90, a quick ratio of 0.69 and a debt-to-equity ratio of 0.32.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Friday, March 13th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of $0.07 by ($0.15). The business had revenue of $73.67 million during the quarter, compared to analysts’ expectations of $104.55 million. Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. As a group, equities analysts predict that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp increased its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares during the period. Bank of America Corp DE raised its stake in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Bioceres Crop Solutions during the third quarter worth $40,000. Invesco Ltd. purchased a new position in Bioceres Crop Solutions in the 4th quarter valued at $45,000. Finally, PDT Partners LLC grew its position in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after buying an additional 10,449 shares during the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.